Showing 2,405 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

PrEP science

Long-acting injectable multi-drug implant shows promise for HIV prevention and treatment

Editor's pick
EurekAlert
23 September 2019
Changing treatment

FDA Expands Indications for Pifeltro and Delstrigo for HIV

Editor's pick
Medscape (requires free registration)
23 September 2019
Treatment outcomes & life expectancy

What’s causing deaths among HIV-positive people in San Francisco?

Editor's pick
CATIE
23 September 2019
Cardiovascular disease

Switching Back to Older Tenofovir Improves Lipid Levels

Editor's pick
POZ
12 September 2019
Contraception

AVAC’s Take on Updated WHO Guidance on Hormonal Contraception and HIV Risk

Editor's pick
AVAC
29 August 2019
Contraception

Guidance statement - Recommendations on contraceptive methods used by women at high risk of HIV

Editor's pick
World Health Organization
29 August 2019
Treatment outcomes & life expectancy

HIV-positive New Yorkers are living longer but still dying from underlying infection, not just from old age

Editor's pick
EurekAlert
29 August 2019
Side effects

Those Truvada Lawsuit Ads You See Everywhere May Hinder Public Health Efforts

Editor's pick
TheBody
28 August 2019
Changing treatment

‘Alarming’ rates of second-line HIV treatment failure in sub-Saharan Africa

Editor's pick
Avert
22 August 2019
HIV treatment for children & young people

Dolutegravir for younger children: results from the ODYSSEY trial

Editor's pick
HIV i-Base
22 August 2019
New & experimental HIV treatments

ViiV Healthcare reports positive phase III study results of investigational, long-acting, injectable HIV-treatment regimen administered every two months

Editor's pick
GSK press release
22 August 2019
Bad science & bogus treatments

Catfished by a Fake AIDS Conference!

Editor's pick
TheBody
20 August 2019
Kidney problems

Change in Kidney Function After TDF-to-TAF Switch: Who Benefits Most?

Editor's pick
NATAP
10 August 2019
Injectable & long-acting HIV treatment

DURECT and Gilead Enter into License Agreement for Long-Acting Injectable HIV Investigational Product

Editor's pick
DURECT press release
6 August 2019
Resistance

Alarming surge in drug-resistant HIV uncovered

Editor's pick
Nature
3 August 2019
Changing treatment

High efficacy from switching to bictegravir/F/TAF in virally suppressed participants – including analyses by baseline drug resistance

Editor's pick
i-Base
2 August 2019
People with limited treatment options

Clinical and Economic Effects of Ibalizumab for Multidrug-Resistant HIV

Editor's pick
Infectious Disease Advisor
2 August 2019
Injectable & long-acting HIV treatment

ViiV Healthcare submits regulatory application to EMA for the first monthly, injectable treatment for HIV

Editor's pick
ViiV press release
30 July 2019
People with limited treatment options

EMA panel recommends ibalizumab for multidrug-resistant HIV-1

Editor's pick
Medscape (requires free registration)
30 July 2019
Treatment for women

What’s in a pill? Promise, uncertainty, rands, lives & loves … but rights? What the next big thing in HIV treatment for SA shows us

Editor's pick
Bhekisisa
29 July 2019
Changing treatment

Biktarvy Suppresses HIV Well in Women and Those With Drug Resistance

Editor's pick
POZ
29 July 2019
Starting treatment

Africa: What are we to make of the ADVANCE trial results?

Editor's pick
Spotlight
25 July 2019
Child developmental issues

Folic acid reduces risk of defects linked to dolutegravir

Editor's pick
Baylor College of Medicine
25 July 2019
Pharmaceutical industry

Can new Dovato data jump-start uptake of 2-drug HIV regimen? ViiV hopes so

Editor's pick
FiercePharma
24 July 2019